Abstract Background & Aims Hepatitis C virus (HCV) continues to pose significant public
health concerns with approximately 44% of chronically infected Canadians undiagnosed …

Background Timely diagnosis and treatment of hepatitis C virus (HCV) is critical to achieve
elimination goals. This study evaluated the cost-effectiveness of point-of-care testing …

Abstract Background: Hepatitis C virus (HCV) infection is an emerging problem in public
health. In most countries, the majority of HCV infected people are yet undiagnosed. Early …

Background & Aims Affordable point-of-care tests for hepatitis C (HCV) viraemia are needed
to improve access to treatment in low-and middle-income countries. Our aims were to …

Methods A published decision-tree plus Markov model was used to compare the expected
costs and quality-adjusted life years (QALY) between one-time universal HCV screening …

Background and Aims This study aims to investigate the cost-effectiveness of a one-time
hepatitis C virus (HCV) screening and treatment program in South Korea where hepatitis B …

E584 CMAJ| APRIL 24, 2017| VOLUME 189| ISSUE 16 complications, including death,
remained higher than for the general population. 9 Another retrospective cohort study found …

Background & Aims Approximately 10 million people live with chronic HCV infection in
China, and less than 20% of people with HCV were diagnosed. We aim to determine the …

Background Point-of-care hepatitis C virus (HCV) RNA testing offers an advantage over
antibody testing (which only indicates previous exposure), enabling diagnosis of active …

Abstract (See the Editorial Commentary by Deuffic-Burban and Yazdanpanah, on pages
1272–4.) Background. Current US guidelines recommend limiting hepatitis C virus (HCV) …